Source: PR Newswire

Press Release: RadiaDyn : RadiaDyne Announces The Sale Of Their OARtrac Patient Dose Monitoring System To University Hospital's Cleveland Medical Center (UH), Located In Cleveland, Ohio

HOUSTON, March 22, 2018 /PRNewswire/ -- RadiaDyne announces milestone commercial sale of their OARtrac system, a transformational diagnostic patient dose monitoring platform to one of the leaders in cancer treatment, University Hospital's Cleveland Medical Center (UH), located in Cleveland...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
John Isham's photo - Founder & CEO of RadiaDyn

Founder & CEO

John Isham

CEO Approval Rating

81/100

Read more